Loading...
Genetic Testing And Global Launches Will Expand Rare Disease Access
AnalystHighTarget's Fair Value
US$89.00
16.4% undervalued intrinsic discount11 Sep
US$74.38
1Y
90.9%7D
0.09%1Y
90.9%7D
0.09%You can edit this narrative until Aug 29 9:20 PM. Then, changes will post as Updates.